Ophthalmic beta blockers: treatment for acute migraine?
- PMID: 25211853
- PMCID: PMC6179475
Ophthalmic beta blockers: treatment for acute migraine?
Comment on
-
Beta blocker eye drops for treatment of acute migraine.Mo Med. 2014 Jul-Aug;111(4):283-8. Mo Med. 2014. PMID: 25211851 Free PMC article. Review.
Similar articles
-
Beta blocker eye drops for treatment of acute migraine.Mo Med. 2014 Jul-Aug;111(4):283-8. Mo Med. 2014. PMID: 25211851 Free PMC article. Review.
-
Can topical beta blockers be successful for acute migraine management?Mo Med. 2014 Jul-Aug;111(4):294-6. Mo Med. 2014. PMID: 25211854 Free PMC article. No abstract available.
-
Topical beta-blocker treatment for migraine.Int Ophthalmol. 2012 Feb;32(1):85-8. doi: 10.1007/s10792-012-9516-6. Epub 2012 Jan 26. Int Ophthalmol. 2012. PMID: 22278763
-
Are drops the solution? A eureka moment? Beta blocker eye drops for acute migraines.Mo Med. 2014 Jul-Aug;111(4):280-1. Mo Med. 2014. PMID: 25211850 Free PMC article. No abstract available.
-
[Migraine in childhood].Rev Neurol. 1995;23 Suppl 2:S232-7. Rev Neurol. 1995. PMID: 7497294 Review. Spanish. No abstract available.
Cited by
-
Nasally Delivered 0.5% Timolol Beta Blocker Successfully Treats Acute Migraines in a Referral Headache Clinic: A Case Series.Mo Med. 2024 Jan-Feb;121(1):33-36. Mo Med. 2024. PMID: 38404426 Free PMC article.
-
A Randomized, Double-Blinded, Placebo-Controlled, Cross Over Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine.Kans J Med. 2020 Feb 26;13(Suppl 2):2-5. eCollection 2020. Kans J Med. 2020. PMID: 32256967 Free PMC article.
-
It Should Not Be This Difficult to Engage Pharma in an Effective, Safe, Inexpensive Product for Acute Migraine, the Third Most Prevalent Disease in the World.Mo Med. 2022 Jan-Feb;119(1):4-6. Mo Med. 2022. PMID: 36033146 Free PMC article. No abstract available.
References
-
- Lipton RB, Diamond S, Reed M, et al. Migraine diagnosis and treatment: results from the American Migraine Study II. Headache. 2001;41:638–645. - PubMed
-
- Ferrari MD, Roon KI, Lipton RB, Goadsby PJ. Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet. 2001;358(929):1668–1675. - PubMed
-
- Cady RJ, Shade CL, Cady RK. Advances in drug development for acute migraine. Drugs. 2012;72(17):2187–2205. - PubMed
-
- Bigal M, Rapoport A, Aurora S, et al. Satisfaction with current migraine therapy: experience from 3 centers in US and Sweden. Headache. 2007;47:475–479. - PubMed
-
- Tepper SJ, Rapoport SJ, Sheftell FD. Mechanisms of action of the 5-HT1B?D receptor agonists. Achives of neurology. 2002;59(7):1084–1088. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical